feed,title,long_url,short_url
Benzinga,Epizyme Stock Gains On Potential $310M Pact With HUTCHMED For Cancer-Focused Tazverik In Greater China,https://benzinga.com/general/biotech/21/08/22393755/epizyme-stock-gains-on-potential-310m-pact-with-hutchmed-for-cancer-focused-tazverik-in-greater-c,https://j.mp/3fL6Abq
